Advances in biotechnology, or “technology that applies to and/or is enabled by life sciences innovation or product development” (National Institute of Standards and Technology, 2022), present vast ...

The biotech sector is very defensive and non-cyclical due to the necessity of medications and healthcare treatment being largely independent of economic growth and market risk sentiment. Money is ...

We’re tackling biotechnology this month, a technology area with which AFCEA isn’t traditionally aligned. But we see a developing synergy between this burgeoning discipline and national security and ...

Like other commissions set up by Congress—such as the Cyberspace Solarium Commission that provided crucial cybersecurity measures—the National Security Commission on Emerging Biotechnology (NSCEB) was ...

In trading on Friday, biotechnology shares were relative leaders, up on the day by about 2.5%. Leading the group were shares of Inozyme Pharma, up about 177.5% and shares of Emergent BioSolutions up ...

In trading on Wednesday, biotechnology shares were relative laggards, down on the day by about 2.7%. Helping drag down the group were shares of REGENXBIO, off about 17% and shares of Forte Biosciences ...

Two top officials from the Pentagon’s Office of the Assistant Secretary of Defense for Science & Technology (OASD(S&T)) highlighted ways the Defense Department (DoD) is leading the charge on ...

On Dec. 10, 2025, the House of Representatives passed a compromise version of the fiscal year 2026 National Defense Authorization Act (NDAA), by a vote of 312 to 112. The legislation includes the ...

The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

The U.S. is falling behind in biotechnology development, Sen. Todd Young, R-Ind., said Wednesday—adding that he and other lawmakers are working to help the country catch up with China’s push to ...

Three top-ranked healthcare funds offer diversification and market defense, with strong returns and exposure to biotech, pharma and health sciences.

Congress established the National Security Commission on Emerging Biotechnology (NSCEB) in the Fiscal Year 2022 National Defense Authorization Act “to examine and make recommendations with respect to ...